In the midst of the uncertainty of the COVID-19 pandemic, it is important for us to be grounded in something bigger than ourselves. At Neurelis, our main focus is the well-being of our patients, healthcare providers, and employees. Our company was founded to solve the unmet needs in epilepsy that have persisted for far too long. We are more focused than ever on addressing those needs.

The AMCP is the nation’s leading professional association dedicated to increasing patient access to affordable medicines, improving health outcomes and ensuring the wise use of healthcare dollars. Through evidence- and value-based strategies and practices, the Academy’s 8,000 pharmacists, physicians, nurses, and other practitioners manage medication therapies for the 270 million Americans served by health plans, pharmacy benefit management firms, emerging care models, and government.

The AANN is committed to working for the highest standard of care for neuroscience patients by advancing the science and practice of neuroscience nursing. Founded in 1968, AANN is an organization of more than 5,200 nurses and healthcare providers worldwide.

The CNF is a 501(c)(3) organization committed to serving as the collaborative center of education and support for children and families living with neurologic conditions.

Neurelis is a member of CNF’s 2018 Corporate Advisory Board (CAB). A forum which connects patient advocates, healthcare providers, and industry leadership to discuss evolving trends and needs of the child neurology community. The goal of CNF’s CAB is to identify collaborative strategies for solutions.